Floatz logo

Tenofovir Disoproxil Fumarate

HIV Infectious Disease

José Antonio Mata MarínSmall moleculePhase 4 / ApprovedActive
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
66/ 100
Competitive Position
81/ 100

Competitive context

58 Active assets in the HIV Infectious Disease cohort.

Asset / SponsorPhaseRating
Raltegravir
Helsinki University Central Hospital
Phase 4A
Retrovir
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Phase 4BBB
Efavirenz
The Cleveland Clinic
Phase 4BBB
NORVIR
Giovanni Di Perri
Phase 4BBB
Dolutegravir
Instituto Mexicano del Seguro Social
Phase 4BBB

View all 46 →

Same molecule, other indications

Tenofovir Disoproxil Fumarate is also rated in:

chronic hepatitis B virus infectionActive
BBB
Indicative · Phase 4
72 / 100
View asset →
lipodystrophyDormant
BB
Indicative · Phase 4
69 / 100
View asset →
sleep disorder, initiating and maintaining sleepDormant
BB
Indicative · Phase 4
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →